Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation

Chest

Volumn 134, Issue 1, 2008, Pages 20-29

  Leiva, Magdalena ^a   Ruiz Bravo, Alfonso ^a   Jimenez Valera, Maria ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Airway inflammation; Antiinflammatory activity; Apoptosis; Macrophage inflammatory protein 2; Neutrophil recruitment; Nuclear factor B inhibition; Telithromycin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; NITRITE; TELITHROMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; EXPERIMENTAL MODEL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MACROPHAGE; MOUSE; NEBULIZATION; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SUPERNATANT; TREATMENT OUTCOME;

EID: 47549095557     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-3056     Document Type: Article

References (39)

1. Berg JT, Lee ST, Thepen T, et al. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphate. J Appl Physiol 1993; 74:2812-2819
2. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109:699-705
3. Palsson-McDermott EM, O'Neill LAJ. Signal transduction by lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004; 113:153-162
4. Verstak B, Hertzog P, Mansell A. Toll-like receptor signalling and the clinical benefits that lie within. Inflamm Res 2007; 56:1-10
5. Blackwell TS, Christman JW. The role of Nf-kB in cytokine gene regulation. Am J Respir Cell Mol Physiol 1997; 17:3-9
6. Poynter ME, Irvin CG, Janssen-Heininger YMW. A prominent role for airway epithelial NF-κB activation in lipopolysaccharide-induced airway inflammation. J Immunol 2003; 170:6257-6265
7. Park GY, Christman JW. Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Targets 2006; 7:661-668
8. Bryskier A. Ketolides: telithromycin, an example of a new class of antibacterial agents. Clin Microbiol Infect 2000; 6:661-669
9. Lomks JR, Goldmann DA. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections. Clin Infect Dis 2005; 40:1657-1664
10. Nguyen M, Chung EP. Telithromycin: the first ketolide antimicrobial. Clin Ther 2005; 27:1144-1163
11. Vazifeh D, Preira A, Bryskier A, et al. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob Agents Chemother 1998; 42:1944-1951
12. Araujo FG, Slifer TL, Remington JS. Inhibition of secretion of interleukin-1α and tumor necrosis factor alpha by the ketolide antibiotic telithromycin. Antimicrob Agents Chemother 2002; 46:3327-3330
13. Nakagawa S, Kojio S, Taneike I, et al. Inhibitory action of telithromycin against Shiga toxin and endotoxin. Biochem Biophys Res Commun 2003; 310:1194-1199
14. Lotter K, Ho¨cherl K, Bucher M, et al. In vivo efficacy of telithromycin on cytokine and nitric oxide formation in lipopolysaccharide- induced acute systemic inflammation in mice. J Antimicrob Chemother 2006; 58:615-621
15. Leiva M, Ruiz-Bravo A, Moreno E, et al. The anti-inflammatory activity of telithromycin in a mouse model of septic shock. Int J Antimicrob Agents 2007; 29:356-365
16. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-138
17. Menge C, Wieler LH, Schlapp T, et al. Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro. Infect Immun 1999; 67:2209-2217
18. Standiford TJ, Kunkel SL, Basha MA, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest 1990; 86:1945-1953
19. Tao F, Kobzik L. Lung macrophage-epithelial cell interactions amplify particle-mediated cytokine release. Am J Respir Cell Mol Biol 2002; 26:499-505
20. Barrett EG, Johnston C, Oberdorster G, et al. Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-α. Am J Physiol 1998; 275:L1110-L1119
21. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-kB. Mol Cell Biol 1990; 10:1498-1506
22. Driscoll KE, Hassenbein DG, Howard BW, et al. Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen. J Leukoc Biol 1995; 58:359-364
23. Fadok VA, Bratton DL, Henson PM. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 2001; 108:957-962
24. Tassiulas I, Park-Min KH, Hu Y, et al. Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum Immunol 2007; 68:156-164
25. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997; 61:375-380
26. Terenzi F, Diaz-Guerra MJ, Casado M, et al. Bacterial lipopeptides induce nitric oxide-independent pathways in rat macrophages. J Biol Chem 1995; 270:6017-6021
27. Bosca L, Hortelano S. Mechanisms of nitric oxide-dependent apoptosis: involvement of mitochondrial mediators. Cell Signal 1999; 11:239-244
28. Ward C, Chilvers ER, Lawson MF, et al. NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999; 274:4309-4318
29. Hortelano S, Castrillo A, Alvarez AM, et al. Contribution of cyclopentenone prostraglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. J Immunol 2000; 165:6525-6531
30. Fitzpatrick LR, Wang J, Le T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-κB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J Pharmacol Exp Ther 2001; 299:915-920
31. Negrotto S, Malaver E, Alvarez ME, et al. Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli. J Pharmacol Exp Ther 2006; 319:972-979
32. Llaudet L, Mabley JG, Pacher P, et al. Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Ann Surg 2002; 235:568-578
33. Heflin AC, Brigham KL. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981; 68:1253-1260
34. Cigana C, Assael BM, Melotti P. Azithromycin selectively erduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother 2007; 51:975-981
35. Hardy RD, Rios AM, Chavez-Bueno S, et al. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. An-timicrob Agents Chemother 2003; 47:1614-1620
36. Urasaki Y, Nori M, Iwata S, et al. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages. J Rheumatol 2005; 32:1765-1774
37. Ogawa N, Sugawara Y, Fujiwara Y, et al. Roxithromycin promotes lymphocyte apoptosis in Dermatophagoides-sensitive asthma patients. Eur J Pharmacol 2003; 474:273-281
38. Kadota JI, Mizunoe S, Kishi K, et al. Antibiotic-induced apoptosis in human activated peripheral lymphocytes. Int J Antimicrob Agents 2005; 25:216-220
39. Aoshiba K, Nagal A, Konno K. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 1995; 39:872-877